HomeNewsWorld NewsFDA Wants Safer Cancer Drugs, But Some Startups Fear Unintended Consequences

FDA Wants Safer Cancer Drugs, But Some Startups Fear Unintended Consequences

For decades cancer drugmakers have taken a more-is-more model when dosing drugs in clinical trials. U.S. regulators want them to reconsider that approach.

Leave a Reply

Your email address will not be published. Required fields are marked *

Disclaimer:

Copyright: © 2023 iSeekFX. All Rights Reserved.